摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(5-bromopyrimidin-2-yl)-4H-1,2,4-triazole-3-thiol | 1516947-99-1

中文名称
——
中文别名
——
英文名称
5-(5-bromopyrimidin-2-yl)-4H-1,2,4-triazole-3-thiol
英文别名
5-(5-bromopyrimidin-2-yl)-1,2-dihydro-1,2,4-triazole-3-thione
5-(5-bromopyrimidin-2-yl)-4H-1,2,4-triazole-3-thiol化学式
CAS
1516947-99-1
化学式
C6H4BrN5S
mdl
——
分子量
258.101
InChiKey
MQWANWBSQIXNRJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    94.3
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • AROMATIC HETEROCYCLIC COMPOUND
    申请人:Mitsubishi Tanabe Pharma Corporation
    公开号:EP2862856A1
    公开(公告)日:2015-04-22
    The compound represented by the general formula: wherein ring A is benzene which may be substituted and the like; ring B is benzene which may be substituted and the like; X is a single bond and the like; Y is alkyl which may be substituted and the like; Z is CR1 or nitrogen atom; R1 is hydrogen and the like; R2 is alkyl which may be substituted and the like or a pharmaceutically acceptable salt thereof is useful as a prevention/treatment agent of obesity, diabetes, and the like.
    由通式表示的化合物:其中环 A 是苯,可被取代等;环 B 是苯,可被取代等;X 是单键等;Y 是烷基,可被取代等;Z 是 CR1 或氮原子;R1 是氢等;R2 是烷基,可被取代等或其药学上可接受的盐,可用作肥胖症、糖尿病等的预防/治疗剂。
  • Aromatic heterocyclic compound
    申请人:MITSUBISHI TANABE PHARMA CORPORATION
    公开号:US10308636B2
    公开(公告)日:2019-06-04
    The compound represented by the general formula: wherein ring A is benzene which may be substituted and the like; ring B is benzene which may be substituted and the like; X is a single bond and the like; Y is alkyl which may be substituted and the like; Z is CR1 or nitrogen atom; R1 is hydrogen and the like; R2 is alkyl which may be substituted and the like or a pharmaceutically acceptable salt thereof is useful as a prevention/treatment agent of obesity, diabetes, and the like.
    由通式表示的化合物:其中环 A 是苯,可被取代等;环 B 是苯,可被取代等;X 是单键等;Y 是烷基,可被取代等;Z 是 CR1 或氮原子;R1 是氢等;R2 是烷基,可被取代等或其药学上可接受的盐,可用作肥胖症、糖尿病等的预防/治疗剂。
  • IMIDAZOLE AND TRIAZOLE COMPOUNDS AS DGAT-1 INHIBITORS
    申请人:Mitsubishi Tanabe Pharma Corporation
    公开号:EP2862856B1
    公开(公告)日:2018-08-01
  • US9546155B2
    申请人:——
    公开号:US9546155B2
    公开(公告)日:2017-01-17
查看更多